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Abstract

Drug-induced orthostatic hypotension (Olf) is a commonside tifftct cfheterocyclic and AfAOI
antidepressant medications. It usually does not respond to conservative treatment and drug
treatments with mineralocorticoids or central dopaminergic antagonists such as metoclopramide
have significant long-term side tifftcts that limit their use. Domperidone, a peripherally acting
dopaminergic antagonist withjew side effects, has been used in a number qfsmall clinical trials to
treat OH qf various etiologies. We reviewed 9 studies qf domperidone in the treatment qf OH.
A lthough limited by small sample sizes and poor design, these studiesgenerally showed successful
treatment of OH by domperidone. Further controlled studies qf domperidone for antidepressantinduced OH in relevant patient samples are warranted.

INTROD UCTION

Drug-induced orthostatic hypot en sion (O H), a com mo n side effect of heterocyclic a nd mon oamine ox idase inhibitor (MAO I) a n tide pressan ts, is often e ncou nte red
in clinica l practi ce (1,2). One st udy found th at seve re sym pto matic O H (repeated
fainting or fall in g) occ urre d in 9% of pat ients on imi pra mi ne, I I % of patients on
ph en elzin e, and 17% of pati ent s on tranylcypromin e (3). The adve rse co nseq uen ces of
drug-induced OH are evide n t, particul arly for th e elde rly whe re fa lls can result in
broken hips . Newer ant idepressants suc h as se ro to ne rg ic reupt ak e inhibit ors do not
ca use significa n t blood pressure cha nges. H owever, so me patient s may need treatm ent with het erocyclics a nd MAOIs because of refr act ory depression or specificity of
resp on se. For exa m ple, patients m ay be preferentiall y resp on sive to MAO Is for
a ne rg ic bipolar d epressions (4) or at ypical d epression s (5) . Thu s, for some patients it
is important to treat side effec ts suc h as OH rath er th an to swi tc h to anoth er
a nt ide pressa n t.
Drug-induced OH, however, is ofte n difficult to manage (6). Conservative
treatm ents su ch as pati ent ed uca tion, vascular s toc kings, increased salt and increased fluid int ak e a re usu all y insufficient. Fludrocortison e, a mi ne ra locorticoid
volum e expa nde r, has been th e mo st co m mo nly used ph arm acologic agent for
a n tide pressan t-ind uce d OH. Fludrocortison e is effec tive in treating OH, but carri es
sign ifican t side effects suc h as resting hypert en sion , hypokal emia and congestive
heart fai lure as well as ot her possibl e co r ticos teroid effec ts. Dop a mi ne rgic antago12
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nist s suc h as m et acl opramide have been exte ns ively used as a trea t me nt for OH in
Parkinson s di sease a nd a u to no m ic neurop athi es, a nd have also been successful in th e
treatm ent of MAOI-indu ced OH (7) . Lik e ot he r ph en othiazine dru gs, met acl opramide act s ce n t rally a nd also has pot entiall y signifi cant side effects including ex t ra pyramidal sym ptoms, hyp erprolactinemia a nd tardive dyskin esia .
Domperidone (trad en am e: Motilium) is a periph eral dop amin e a ntagonist th at
does not cross th e blood brain barri er, ha s no ce nt ra l dop amin ergic ac tivity, and
th e refore is devoid of th es e risks (8) . Recently domperidon e has bee n successfully
used in sm a ll clinical trials for OH secondary to Pa rk inson s diseas e, diab etic
a u to no m ic neuropathy, ce n t ral neurological inju ry a nd d r ug-induced OH. T his
a r ticle will review th e lit erature add ress ing domperidon e as a t reatm e nt of OH. O ur
lit erature searc h reveal ed only nin e a r ticles focu sin g on domperid one a nd ort hostatic
hypot en sion.
Domperidon e is m ainly used as a n upper gas t ro in tes tina l mo ti lity age n t (9).
Lik e m etoclopramid e, it has anti em etic a nd gas t ro p ro kine tic pr op erti es. Dom pe ridone is gen erally well tol erat ed and has a low incid en ce of sid e effects, pred om ina n tly
dry mouth (1.9 %) , headach e (1.2 %), a bdo m inal cra m ps « 1%), a nd diarrhea « 1%)
( 10). Althou gh it has no ce nt ral effects it ca n rai se p rol acti n levels ( 10). It s usual
dosage ran ge is 30 to 60 mg daily for upper gas troin tes tina l mot ility d isord ers.
Becau se of it s a n tie me tic prop erties, domp eridone was used to treat t he nau sea
a nd e me sis associa te d with dopamin ergic age n ts in th e t reat m en t of Pa rkinsons
d isease. The dop amine agoni st a po mo rp hine a lso ca uses O H , likely m ed iat ed
throu gh peripheral , rather th an ce n t ra l, dop aminergic mech an ism s ( I I ) . A doubleblind st udy (12) in 4 dru g-free pati ents with Parkinson s di sease found th e ac ute
administration of domperidone (100 ug/kg 1M), but not sa line, pr event ed th e
nausea , sed a tion, a nd art erial hypot ension seen aft er a pomo r phine inj ection (20
ug/kg 1M). Poll ack e t al. (13) also st ud ied both th e acu te a nd chro nic blood pr essu re
effec ts of domperidon e in two se pa ra te st ud ies of patients with Parkinsonis m. In a
sing le-blind st udy involvin g 10 pati ents, domperidon e ( 12 mg 1M) or placeb o was
ad m iniste re d , followed by I m g of a po mo r phine. In th e placeb o co nd ition, a po morphine sign ifican tly lowered supine a nd e rect blood pr essures. Th e domperidone
sig nifica n tly incr eased sup ine diastolic blood pr essure, erect systolic a nd d iast olic
blood pr essure, and block ed th e hypot en sive effects of a po mo rp hine. T he second
s t udy exa m ine d th e lon ger-t erm blood pr essure effects of domperidon e in 16 pati ent s
with idiopathic Parkinson s dis eas e ch ro n ica lly treat ed with a variet y of dop a mi ne rgic
drugs. Five of th es e patients had occasional asym p tom a tic OH. Pati ent s we re give n
eit he r pla cebo or domperidone for on e week in a double blind cross-ove r design . In
th ese pati ents domperidon e slightly, but significa n tly, rai sed sup ine systo lic blood
pr essure a nd e rect sys tolic a nd di astolic blood pr essure ove r th e on e-week period.
These e ncouraging results were not suppo rte d in ot her s t ud ies wit h domperi don e a nd brom ocriptine. Agid e t a l. found th at domp e ridone (60 mg/day) block ed
brom ocriptine-induced nau sea a nd vom iting a nd allowed for ra pid a ttain me nt of
high th erapeutic dos es of bromocriptine ( 14). There was, however, no prot ect ion
agains t hypot ension in thi s placeb o-controlled st udy. All fou r pa tie nt s who had
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ort hos tatic hypot en sion (out of a tot al of 17 subjects) were in th e dom pe ridone group.
Two furth er report s by th e sa m e gro up found th at larger doses of domperidon e (150
m g/day) had no effec t on blood pr essure nor th e occ u r re nce of ort hos ta tic hypot e nsion in 20 patients treat ed with high-dose brom ocriptin e ( 15, 16), a lt ho ug h th ese two
rep orts se e m to co nsist of th e sa me patient sa m ple. This discre pan cy in result s wit h
bromocriptine a nd a po mo rp hine sugges ts th at br om ocriptine-in d uced postural hypot en sion involves ce n t ral m ech anisms rather th an periph e ral m echan isms.
Althou gh th ese st ud ies of domperidon e a nd dop amine ago nist s have shown
mixed results on blood pr essure effects, clinical st ud ies of domperidone in treat ing
OH hav e ge nera lly been favorabl e. One rep ort found th at d ompe ridone (60 mg/day)
was effec tive for treating th e OH of3 hypert en sive pati ent s with conc u r re n t OH from
seve ra l e tiolog ies (17). Mont astruc c t a l. (I8) looked a t domp e rid on c's effec ts in 8
patients with "severe sym p tom a tic or t hosta tic hypot en sion " of va rious e tiolog ies (3
patients had ce n t ra l neurological injury, 2 cases had idiopathic OH, a nd 3 pa tien ts
had drug-induced OH du e to clomipramine or antimitotic m edi cation ). Aft er 5 days
of treatm ent with domperidone OH improved a nd sym p to ms disappea red in all
cases. Aft er 5.0 ± 1.4 months mean follow-up th e ort hos ta tic d rop was significan tly
reduced from 53.1 ± 4 mmHg before treatm ent to 25.0 ± 9.5 m mHg afte r
domperidone. Domperidone ha s a lso been effective in treating sym p tomatic OH in
diabetic a u tonom ic neuropathy (19). Lopes de Fari a et a l. (20) st ud ied 9 pati ent s with
di ab etic a u to no m ic neurop athy a nd showed th at ora l domperid one 30 m g/day for 3
days significa n tly decreased th e ort hos ta tic drop in blood pr essure. Six of th ese
patients maintained th eir im prove me n t a fte r a 6-mo n t h follow-up.
DISC USSIO

T

Th e m ech anism of ac tion of domperidon e on blood pressure rem ains poorl y
underst ood . Peripherall y ac ting d op amine may have vasod ilat ing and naturi eti c
effects, and excessive dop amin e release up on sta nd ing has been d escribed in pat ient s
with OH (2 1). M et oclopramide is hypothesized to inhibit th ese effec ts and incr ease
plasma levels of aldost erone and free e pineph rine (22) . Domperidon e's peripheral
dopamin ergic block ad e may have sim ila r effec ts . Domperidon e is a lso a spec ific
a n tagon ist of D2 pr esynapti c dopamin e recept ors (23) . Si nce norepineph rin e release
is inhibit ed by dopaminergic activity on D2 receptors, domperidon e 's effec t on O H
may be m ediat ed through e nha nce me nt of peripheral noradren e rgic act ivity. Preliminary st ud ies, how ever, hav e not found significa n t incr eases in plasm a re nin activit y,
ald ost erone, responsiven ess to a ng iote ns in II , nor urinary ca techo lam ines th at might
explain th e postural blood pr essure cha nges followin g domperidon e (20) .
In su m m ary, this review indi cat es that domperidon e was effective in t he treatm ent of sym ptom a tic OH du e to varied ca uses including di ab etic neu ro pat hy, ce ntral
neurological inju ry, Parkinsoni sm a nd so m e dru g-induced OH. Howeve r, t hese
st ud ies a re limit ed by small sam ple sizes, ope n clinica l d esign s, a nd th e inclu sion of
m u lt iple e tiologies for OH. one com pared domp eridon e to ot he r effec tive treat m ent s for OH. The mechanism for domperidon e's act ion on blood pressu re is
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unknown , so domperidone may be effec tive on ly for ce rtain etiolog ies of OH . Only
on e pati ent in th es e st ud ies had a n tide pressan t-ind uce d OH . H oweve r, he te rocyclic
and MAOI a n tide p ress a n ts co nt in ue to be essen tia l tools in our psyc hopharmacologi c
a r ma me n ta r iu m, d espit e th eir hypot en sive side effec ts . For some patients with
antid epressant-induced OH, particul arly th ose who did not respond to antidepressa n ts th at do not have OH as a side effect, it will be clinica lly advantageous to treat
th e OH rather than switc hing drugs. Becau se domperidon e is a we ll-tolerat ed
m edi cation with few side effec ts, it will be worthwhil e to det ermine in controlled
s t ud ies wh eth er it is a n effec tive treatm ent for antid epressant -induced O H in t hese
pati ents. Sin ce OH ca n be sym pto matic or asy m p to ma tic, tra nsient or continuous,
future clinical st ud ies shou ld ope ration aliz e th e defin iti on and measurement of OH
in orde r to d et ermine th e clinical versu s statis tica l sign ifica nce of t rea t m e n ts.
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